Innovations in biofilm prevention and eradication in medical sector: an integrative review.

Opis bibliograficzny

Innovations in biofilm prevention and eradication in medical sector: an integrative review. [AUT. KORESP.] KONRAD NIEDŹWIADEK, [AUT.] MAGDALENA POLAK-BERECKA, ADAM WAŚKO. Pathogens 2025 Vol. 14 Iss. 12 Article number: 1242, il., bibliogr., summ. DOI: 10.3390/pathogens14121242
Skopiowane!
Kliknij opis aby skopiować do schowka

Szczegóły publikacji

Źródło:
Pathogens 2025 Vol. 14 Iss. 12, Article number: 1242
Rok: 2025
Język: Angielski
Charakter formalny: Artykuł w czasopismie
Typ MNiSW/MEiN: praca oryginalna

Streszczenia

Background: Biofilm-associated infections remain a major challenge in modern medicine due to their high resistance to antibiotics and immune defences. Advances in materials science, chemistry, and nanotechnology have led to the development of innovative, non-antibiotic approaches to prevent or eradicate biofilms. Methods: This review summarises antibiofilm strategies reported between 2020 and 2025, grouped into chemical, enzymatic, physical–photonic, nanomaterial-based, and biological hybrid categories. Results: Chemical methods such as silver-based chemical systems, nitric oxide donors, and biosurfactants disrupt bacterial membranes, generate reactive oxygen species, and inhibit quorum sensing. Enzymatic coatings with DNase I or lysostaphin effectively reduce Staphylococcus aureus and S. epidermidis biofilms, showing stability after sterilisation and high biocompatibility. Physical–photonic techniques, including photocatalytic and light-activated coatings, provide controllable and renewable antibacterial activity. Nanomaterials such as silver nanomaterials, chitosan-based carriers, magnetic ferrites, and catalytic nanozymes enable targeted, ROS-mediated biofilm disruption. Biologically derived systems, including bacteriophage hydrogels and plant metabolites, offer eco-friendly, biocompatible alternatives. Conclusions: Recent antibiofilm innovations mark a transition from conventional antibiotics to multifunctional and adaptive systems integrating chemical, enzymatic, and physical mechanisms for effective biofilm control on medical surfaces.

Identyfikatory

BPP ID: (46, 53257) wydawnictwo ciągłe #53257

Metryki

100,00
Punkty MNiSW/MEiN
3,300
Impact Factor
Q2
WoS

Eksport cytowania

Wsparcie dla menedżerów bibliografii:
Ta strona wspiera automatyczny import do Zotero, Mendeley i EndNote. Użytkownicy z zainstalowanym rozszerzeniem przeglądarki mogą zapisać tę publikację jednym kliknięciem - ikona pojawi się automatycznie w pasku narzędzi przeglądarki.

Skopiowane!

Informacje dodatkowe

Rekord utworzony:5 grudnia 2025 12:07
Ostatnia aktualizacja:7 stycznia 2026 12:35